Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.
Amino Acid Substitution
Animals
Brain
/ virology
Cell Adhesion Molecules
/ metabolism
Chlorocebus aethiops
Epidemics
Female
Genotype
Giant Cells
/ virology
HEK293 Cells
Humans
Male
Measles
/ epidemiology
Measles virus
/ genetics
Mutation
Neurons
/ virology
South Africa
Subacute Sclerosing Panencephalitis
/ genetics
Vero Cells
Viral Fusion Proteins
/ genetics
central nervous system infections
measles
viral fusion
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
15 02 2019
15 02 2019
Historique:
received:
09
10
2018
accepted:
20
11
2018
pubmed:
30
11
2018
medline:
7
1
2020
entrez:
30
11
2018
Statut:
epublish
Résumé
During a measles virus (MeV) epidemic in 2009 in South Africa, measles inclusion body encephalitis (MIBE) was identified in several HIV-infected patients. Years later, children are presenting with subacute sclerosing panencephalitis (SSPE). To investigate the features of established MeV neuronal infections, viral sequences were analyzed from brain tissue samples of a single SSPE case and compared with MIBE sequences previously obtained from patients infected during the same epidemic. Both the SSPE and the MIBE viruses had amino acid substitutions in the ectodomain of the F protein that confer enhanced fusion properties. Functional analysis of the fusion complexes confirmed that both MIBE and SSPE F protein mutations promoted fusion with less dependence on interaction by the viral receptor-binding protein with known MeV receptors. While the SSPE F required the presence of a homotypic attachment protein, MeV H, in order to fuse, MIBE F did not. Both F proteins had decreased thermal stability compared to that of the corresponding wild-type F protein. Finally, recombinant viruses expressing MIBE or SSPE fusion complexes spread in the absence of known MeV receptors, with MIBE F-bearing viruses causing large syncytia in these cells. Our results suggest that alterations to the MeV fusion complex that promote fusion and cell-to-cell spread in the absence of known MeV receptors is a key property for infection of the brain.
Identifiants
pubmed: 30487282
pii: JVI.01700-18
doi: 10.1128/JVI.01700-18
pmc: PMC6364028
pii:
doi:
Substances chimiques
Cell Adhesion Molecules
0
Viral Fusion Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NINDS NIH HHS
ID : R01 NS091263
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS105699
Pays : United States
Informations de copyright
Copyright © 2019 American Society for Microbiology.
Références
J Immunol. 2001 Nov 15;167(10):6009-14
pubmed: 11698481
J Virol. 2012 Dec;86(23):12838-48
pubmed: 22993149
J Virol. 2013 Mar;87(5):2648-59
pubmed: 23255801
EMBO J. 1987 Mar;6(3):681-8
pubmed: 3582370
mBio. 2015 Feb 10;6(1):
pubmed: 25670774
PLoS Pathog. 2011 Aug;7(8):e1002240
pubmed: 21901103
PLoS Pathog. 2010 Oct 28;6(10):e1001168
pubmed: 21060819
Virol J. 2013 Sep 12;10:283
pubmed: 24025157
J Virol. 1998 Feb;72(2):1224-34
pubmed: 9445022
Protein Expr Purif. 2006 Jul;48(1):61-8
pubmed: 16600625
Nature. 2011 Nov 02;480(7378):530-3
pubmed: 22048310
FEMS Microbiol Rev. 2012 May;36(3):649-62
pubmed: 22316382
J Virol. 2013 Aug;87(16):9208-16
pubmed: 23760251
J Virol. 2013 Jan;87(1):314-26
pubmed: 23077316
Virology. 2001 Dec 20;291(2):215-25
pubmed: 11878891
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Virus Res. 2005 Aug;111(2):132-47
pubmed: 15893837
Cell. 1988 Oct 21;55(2):255-65
pubmed: 3167982
J Biol Chem. 2012 Jan 2;287(1):778-93
pubmed: 22110138
J Virol. 2010 Nov;84(21):11189-99
pubmed: 20719945
PLoS One. 2013;8(2):e55682
pubmed: 23437059
Nucleic Acids Res. 1996 Mar 15;24(6):1171-2
pubmed: 8604354
J Virol. 2015 Mar;89(5):2710-7
pubmed: 25520515
J Virol. 2018 Feb 26;92(6):
pubmed: 29298883
J Virol. 2007 Oct;81(19):10567-74
pubmed: 17652384
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2496-2501
pubmed: 29463726
Curr Opin Virol. 2014 Apr;5:16-23
pubmed: 24492202
Nat Struct Mol Biol. 2011 Feb;18(2):135-41
pubmed: 21217702
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
Acta Neuropathol. 1998 Dec;96(6):637-42
pubmed: 9845294
Virology. 1992 Jun;188(2):910-5
pubmed: 1585658
PLoS One. 2014 Apr 18;9(4):e95470
pubmed: 24748123
S Afr Med J. 2015 Sep 14;105(9):713-8
pubmed: 26428963
J Virol. 2015 Jan 15;89(2):1143-55
pubmed: 25378493
Virology. 1986 Oct 15;154(1):97-107
pubmed: 3750847
S Afr Med J. 2011 May;101(5):313-4, 316-7
pubmed: 21837871
EMBO J. 2001 Aug 1;20(15):4024-34
pubmed: 11483506
J Virol. 2002 Dec;76(24):13062-8
pubmed: 12438633
Virus Res. 2007 Dec;130(1-2):260-8
pubmed: 17825451
EMBO J. 1998 Jul 15;17(14):3899-908
pubmed: 9670007